Affinia Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Affinia Therapeutics is a biotechnology research company focused on advancing gene therapies. It aims to broaden the reach of genetic medicines by re-engineering a viral delivery method to address diseases with known genetic causes, moving beyond current limitations. The initial focus is on heart and nervous system diseases, where targeted delivery remains challenging and may enable new treatment paradigms. Based in Waltham, Massachusetts, the company operates with a specialized, early-stage team pursuing first-in-class or best-in-class candidates. In recent activity, Affinia presented data on its lead program for BAG3-associated dilated cardiomyopathy at the ASGCT 2026 Annual Meeting.